Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization.

Fabris L, Cadamuro M, Moserle L, Dziura J, Cong X, Sambado L, Nardo G, Sonzogni A, Colledan M, Furlanetto A, Bassi N, Massani M, Cillo U, Mescoli C, Indraccolo S, Rugge M, Okolicsanyi L, Strazzabosco M.

Hepatology. 2011 Sep 2;54(3):890-9. doi: 10.1002/hep.24466.

2.

Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.

Cadamuro M, Spagnuolo G, Sambado L, Indraccolo S, Nardo G, Rosato A, Brivio S, Caslini C, Stecca T, Massani M, Bassi N, Novelli E, Spirli C, Fabris L, Strazzabosco M.

Cancer Res. 2016 Aug 15;76(16):4775-84. doi: 10.1158/0008-5472.CAN-16-0188. Epub 2016 Jun 21.

3.

The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value.

Tian X, Wang Q, Li Y, Hu J, Wu L, Ding Q, Zhang C.

Pathol Oncol Res. 2015 Jan;21(1):195-201. doi: 10.1007/s12253-014-9806-6. Epub 2014 Jul 2.

PMID:
24985031
4.

Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.

Cadamuro M, Nardo G, Indraccolo S, Dall'olmo L, Sambado L, Moserle L, Franceschet I, Colledan M, Massani M, Stecca T, Bassi N, Morton S, Spirli C, Fiorotto R, Fabris L, Strazzabosco M.

Hepatology. 2013 Sep;58(3):1042-53. doi: 10.1002/hep.26384. Epub 2013 Jul 22.

5.

Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.

Namwat N, Puetkasichonpasutha J, Loilome W, Yongvanit P, Techasen A, Puapairoj A, Sripa B, Tassaneeyakul W, Khuntikeo N, Wongkham S.

J Gastroenterol. 2011 May;46(5):664-75. doi: 10.1007/s00535-010-0345-y. Epub 2010 Nov 13.

PMID:
21076843
6.

Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.

Xu Y, Yao Y, Zhong X, Leng K, Qin W, Qu L, Cui Y, Jiang X.

Biochem Biophys Res Commun. 2018 Feb 5;496(2):455-461. doi: 10.1016/j.bbrc.2018.01.077. Epub 2018 Jan 12.

PMID:
29337065
7.

Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.

Tian F, Li D, Chen J, Liu W, Cai L, Li J, Jiang P, Liu Z, Zhao X, Guo F, Li X, Wang S.

Eur J Cancer. 2013 May;49(7):1771-80. doi: 10.1016/j.ejca.2012.12.015. Epub 2013 Jan 11.

PMID:
23313142
8.

Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression.

Techasen A, Namwat N, Loilome W, Duangkumpha K, Puapairoj A, Saya H, Yongvanit P.

J Hepatobiliary Pancreat Sci. 2014 Sep;21(9):703-11. doi: 10.1002/jhbp.125. Epub 2014 May 27.

PMID:
24867797
9.

Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.

Zhang H, Li Z, Chu B, Zhang F, Zhang Y, Ke F, Chen Y, Xu Y, Liu S, Zhao S, Liang H, Weng M, Wu X, Li M, Wu W, Quan Z, Liu Y, Zhang Y, Gong W.

Tumour Biol. 2016 Jun;37(6):8305-15. doi: 10.1007/s13277-015-4704-4. Epub 2016 Jan 4.

PMID:
26729195
10.

S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.

Bjørnland K, Winberg JO, Odegaard OT, Hovig E, Loennechen T, Aasen AO, Fodstad O, Maelandsmo GM.

Cancer Res. 1999 Sep 15;59(18):4702-8.

11.

An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma.

Nakanuma Y, Uchida T, Sato Y, Uesaka K.

Hum Pathol. 2017 Feb;60:46-57. doi: 10.1016/j.humpath.2016.10.003. Epub 2016 Oct 28.

PMID:
27984121
12.
13.
14.

S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.

Zhang J, Zhang DL, Jiao XL, Dong Q.

Eur Rev Med Pharmacol Sci. 2013 Sep;17(17):2372-82.

15.

Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.

Xu YF, Yang XQ, Lu XF, Guo S, Liu Y, Iqbal M, Ning SL, Yang H, Suo N, Chen YX.

Biochem Biophys Res Commun. 2014 Mar 28;446(1):54-60. doi: 10.1016/j.bbrc.2014.02.050. Epub 2014 Feb 22.

PMID:
24565842
16.

RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.

Yang XC, Wang X, Luo L, Dong DH, Yu QC, Wang XS, Zhao K.

Eur Rev Med Pharmacol Sci. 2013 Jun;17(12):1669-80.

17.
18.

Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.

Utispan K, Thuwajit P, Abiko Y, Charngkaew K, Paupairoj A, Chau-in S, Thuwajit C.

Mol Cancer. 2010 Jan 24;9:13. doi: 10.1186/1476-4598-9-13.

20.

Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.

Xu Y, Wang Z, Jiang X, Cui Y.

Biomed Pharmacother. 2017 Aug;92:17-23. doi: 10.1016/j.biopha.2017.05.061. Epub 2017 May 18.

PMID:
28528181

Supplemental Content

Support Center